
Palatin’s Dual Blockbuster Potential: Obesity and Ulcerative Colitis Results Expected Within Days
Palatin Technologies (NYSE American: PTN) stands at a pivotal moment in its corporate journey, with multiple data readouts expected in the first quarter of 2025 that could significantly transform the company’s trajectory in the increasingly valuable …